I and many others have been critical of Usana Health Sciences (NASDAQ: USNA) for a while now. Fraud fighter Barry Minkow has argued quite compellingly that the company's business model amounts to little more than a cleverly disguised pyramid scheme. How did he figure that out? He read the company's filings with the SEC.
Since Minkow's report, the stock has taken a beating: an auditor resigned, numerous credentials flaps were uncovered, the SEC opened (and closed, sadly) an investigation, and the company has repeatedly failed to meet the growth expectations of the Street.
Now founder Myron Wentz -- who owns half the stock through Gull Holdings -- is offering to take the company private at $26 per share. His reasoning? In the press release announcing the offer, Wentz explained, "Going private will provide significant cost savings and will allow USANA's talented management team, employees, and Associates to focus solely on providing industry-leading products and building USANA's strong Associate network without the pressures and distractions brought on by the public market."
Exactly! Going private will allow the company to operate its shady business model free from scrutiny. The selling of overpriced vitamins based on the promise of the potential to earn a six-figure income working from home has earned a lot of money for Usana. But having to disclose the business model in black and white has attracted the scorn of critics.
Now Usana can go back to what it does best: luring people in to a multi-level marketing business without having to disclose as much information about what a rip-off it is.
But before shareholders get too excited, they might want to take a look at Wentz's history of offering to buy the company. Back in 2002, Wentz made a similar offer (for a lot less money), but then Wentz later announced, "To allow our shareholders to benefit from any increased value, I have decided to terminate my current effort to acquire USANA's operating assets on the terms previously announced."
What a swell guy! This is starting to remind me of the whole Parlux (NASDAQ: PARL) buyout that never was fiasco.
Last updated: February 08, 2012: 12:28 AM
Hot Stocks
DailyFinance Headlines
- Walgreen's Helps Make Fertility a Men's Issue, Too
- Ford Can't Seem to Take a Joke, but It's Not the End of the World
- Would You Pay $1,499 for an Apple Television?
- Micron CEO's Sudden Death Raises Wider Questions on Corporate Successions
- Bank Fee Backlash Cost Big Financial Institutions More Than 2 Million Customers
Benzinga Headlines
- Theorem's Jay Kulkami Talks Shop with Benzinga
- Energy Independence on the Horizon? Two Companies to Consider
- Powering Up: It Might Be 2010 All Over Again For Lithium ETF
- The Real Deal on Wall Street: Can Dunkin Brands Get a Little Love, Please?
- Are Poor Results From UBS A Bad Omen For Europe?
TheFlyOnTheWall.com Headlines
- CIFC Corp. sells non-core assets for $36.5M
- Harvard Bioscience acquires business of AHN Biotechnologie through subsidiary
- Timken and United Steelworkers Local 1123 announce tentative agreement
- Consolidated Graphics increases share repurchase program to $170M from $100M
- Consolidated Graphics sees Q1 revenue $265M-$275M vs. consensus $265.60M
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Walgreen's Helps Make Fertility a Men's Issue, Too
- Ford Can't Seem to Take a Joke, but It's Not the End of the World
- Would You Pay $1,499 for an Apple Television?
- Micron CEO's Sudden Death Raises Wider Questions on Corporate Successions
- Bank Fee Backlash Cost Big Financial Institutions More Than 2 Million Customers
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Savings Experiment: Tissues vs. Toilet Paper
Wrecks to Riches: Hunting Sunken Treasures from Cape Cod to the Costa…


Reader Comments (Page 1 of 1)
6-01-2008 @ 11:25AM
Ryan said...
There's no offer on the table yet from what I'm reading. There's only the offer to make an offer.